Advertisement

Picture EBD Group BIO-Europe 2018 Copenhagen Denmark Partnerships 600x60px
Document › Details

Trivitron Healthcare Pvt. Ltd.. (11/23/12). "Press Release: Global Acquisition by Trivitron Healthcare Paves Its Way to Point of Care Diagnostics".

Organisations Organisation Trivitron Healthcare Pvt. Ltd.
  Group Trivitron (Group)
  Organisation 2 Ani Labsystems Ltd. Oy
  Today Labsystems Diagnostics Oy
  Group Trivitron (Group)
Products Product diagnostic test, rapid (point-of-care)
  Product 2 in vitro diagnostics (IVD)
Index term Index term Ani Labsystems–Trivitron: investment, 201211 acquisition €15.8m of 100% of Ani Labsystems group by Trivitron Healthcare
     


A first of its kind for an Indian Medical Technology Company to go abroad for acquisition with an investment of 15.8 million Euro in Finland.


Trivitron Healthcare announces the 100% acquisition of Ani labsystem, a leader in the In Vitro Diagnostic space with unique global position in the fast growing Neonatal Screening and Cardiac Bio markers screening areas. Ani Labsystems is a group of companies consist of Ani Biotech, Ani Labsystems, Biopoint and K3.

Trivitron is acquiring all these four group companies and the merger is known as Labsystems Diagnostics OY- A Trivitron Group Company. This global joint venture brings forth access to global manufacturing facility, a first of its kind for an Indian Medical Technology Company to go abroad for acquisition.

With this acquisition, Trivitron has the capability to enter into Point of Care Diagnostics, Immuno Diagnostics and Molecular Diagnostics, the three of the fastest growing areas in the In Vitro Diagnostics field. Trivitron is already manufacturing Hematology and Clinical Chemistry kits from their Facilities. Hence this will make Trivitron a global In Vitro Diagnostic company with capability of manufacturing variety of Diagnostics Kits covering all major areas of In Vitro Diagnostics Field

While Neonatal Screening, Cardiac Biomarkers , Gastro and Respiratory diagnostics kits will continue to be manufactured in Finland, the Infectious Diseases and Women's health manufacturing will be shifted to The Trivitron Medical Technology Park based in Chennai.

   
Record changed: 2016-09-18

Advertisement

Picture [iito] – Putting Information into Context 600x102px

More documents for Trivitron (Group)


To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com

Advertisement

Picture Berlin Partner HealthCapital RegMed Forum 2018 October iito 600x60px




» top